A review of exenatide as adjunctive therapy in patients with type 2 diabetes
Gisela I Robles, Devada Singh-FrancoNova Southeastern University, College of Pharmacy, Health Professions Division, Fort Lauderdale, FL, USABackground: Incretin glucagon-like peptide-1 (GLP-1) is a hormone released from cells in the gastrointestinal tract (GI), leading to glucose-dependent...
Saved in:
Main Authors: | Gisela I Robles (Author), Devada Singh-Franco (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
by: Tim A Briscoe, Lynette Jobe, et al.
Published: (2008) -
Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
by: Inaishi J, et al.
Published: (2022) -
Exenatide Use in the Management of Type 2 Diabetes Mellitus
by: Angelos Kyriacou, et al.
Published: (2010) -
Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes
by: Zhang Y, et al.
Published: (2021) -
Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
by: Deng W, et al.
Published: (2015)